Ocular Therapeutix Quarterly Income Statements Chart
Quarterly
|
Annual
Ocular Therapeutix Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| revenue: | |||||||||||||||||||||||||||||||||||||||||||||
| product revenue | 13,395,000 | 10,634,000 | 17,020,000 | 15,347,000 | 16,379,000 | 14,715,000 | 14,677,000 | 14,950,000 | 15,029,000 | 13,214,000 | 13,902,000 | 11,913,000 | 12,144,000 | 12,498,000 | 12,308,000 | 12,153,000 | 11,718,000 | 7,342,000 | 7,349,000 | 5,876,000 | 1,569,000 | 2,609,000 | 2,256,000 | 829,000 | 650,000 | 492,000 | 504,000 | 498,000 | 648,000 | 340,000 | 487,000 | 523,000 | 438,000 | 475,000 | 511,000 | 477,000 | 441,000 | 416,000 | 394,000 | 388,000 | 334,000 | 238,000 | |||
| collaboration revenue | 64,000 | 64,000 | 62,000 | 78,000 | 62,000 | 59,000 | 124,000 | 131,000 | 157,000 | 160,000 | 173,000 | 52,000 | 122,000 | 689,000 | 42,000 | 42,000 | 41,000 | 125,000 | 188,000 | ||||||||||||||||||||||||||
| total revenue | 13,459,000 | 10,698,000 | 17,082,000 | 15,425,000 | 16,441,000 | 14,774,000 | 14,801,000 | 15,081,000 | 15,186,000 | 13,374,000 | 14,075,000 | 11,965,000 | 12,266,000 | 13,187,000 | 12,308,000 | 12,153,000 | 11,718,000 | 7,342,000 | 7,349,000 | 5,876,000 | 1,569,000 | 2,609,000 | 2,256,000 | 829,000 | 650,000 | 492,000 | 504,000 | 498,000 | 648,000 | 340,000 | 487,000 | 523,000 | 438,000 | 475,000 | 458,000 | ||||||||||
| yoy | -18.14% | -27.59% | 15.41% | 2.28% | 8.26% | 10.47% | 5.16% | 26.04% | 23.81% | 1.42% | 14.36% | -1.55% | 4.68% | 79.61% | 67.48% | 106.82% | 646.85% | 181.41% | 225.75% | 608.81% | 141.38% | 430.28% | 347.62% | 66.47% | 0.31% | 44.71% | 3.49% | -4.78% | 47.95% | -28.42% | 3.71% | ||||||||||||||
| qoq | 25.81% | -37.37% | 10.74% | -6.18% | 11.28% | -0.18% | -1.86% | -0.69% | 13.55% | -4.98% | 17.63% | -2.45% | -6.98% | 7.14% | 1.28% | 3.71% | 59.60% | -0.10% | 25.07% | 274.51% | -39.86% | 15.65% | 172.14% | 27.54% | 32.11% | -2.38% | 1.20% | -23.15% | 90.59% | -30.18% | -6.88% | 19.41% | -7.79% | ||||||||||||
| costs and operating expenses: | |||||||||||||||||||||||||||||||||||||||||||||
| cost of product revenue | 1,944,000 | 1,262,000 | 1,230,000 | 1,561,000 | 1,509,000 | 1,326,000 | 1,386,000 | 1,377,000 | 1,304,000 | 1,214,000 | 1,012,000 | 1,073,000 | 1,155,000 | 1,300,000 | 1,108,000 | 1,310,000 | 1,096,000 | 892,000 | 680,000 | 450,000 | 134,000 | 819,000 | 839,000 | 806,000 | 552,000 | 128,000 | 117,000 | 115,000 | 153,000 | 80,000 | 113,000 | 125,000 | 104,000 | 115,000 | 127,000 | 112,000 | 105,000 | 99,000 | 92,000 | 91,000 | 80,000 | 56,000 | |||
| research and development | 51,081,000 | 42,857,000 | 40,989,000 | 37,054,000 | 28,857,000 | 20,735,000 | 16,195,000 | 15,019,000 | 15,094,000 | 14,747,000 | 13,543,000 | 13,719,000 | 13,100,000 | 13,100,000 | 12,578,000 | 12,719,000 | 13,859,000 | 10,927,000 | 7,624,000 | 6,951,000 | 8,021,000 | 6,098,000 | 10,125,000 | 10,235,000 | 9,414,000 | 11,317,000 | 10,258,000 | 9,685,000 | 8,745,000 | 8,227,000 | 7,908,000 | 8,126,000 | 8,117,000 | 6,729,000 | 7,328,000 | 5,686,000 | 6,978,000 | 7,073,000 | 6,886,000 | 8,263,000 | 6,743,000 | 4,719,000 | 5,148,000 | 4,482,000 | 4,292,000 |
| selling and marketing | 13,729,000 | 14,148,000 | 10,840,000 | 10,573,000 | 9,994,000 | 10,183,000 | 9,245,000 | 9,315,000 | 11,153,000 | 10,835,000 | 10,532,000 | 10,186,000 | 10,140,000 | 9,063,000 | 9,136,000 | 9,576,000 | 8,391,000 | 8,086,000 | 6,811,000 | 6,520,000 | 6,153,000 | 7,130,000 | 7,142,000 | 6,777,000 | 7,225,000 | 3,347,000 | 2,291,000 | 1,067,000 | 867,000 | 717,000 | 903,000 | 3,238,000 | 6,832,000 | 6,027,000 | 2,526,000 | 1,294,000 | 1,492,000 | 1,389,000 | 1,143,000 | 798,000 | 1,041,000 | 870,000 | 658,000 | 479,000 | 535,000 |
| general and administrative | 14,346,000 | 16,348,000 | 14,599,000 | 12,235,000 | 19,671,000 | 14,147,000 | 8,025,000 | 8,584,000 | 8,205,000 | 9,127,000 | 8,349,000 | 8,531,000 | 7,787,000 | 7,557,000 | 7,535,000 | 8,077,000 | 8,603,000 | 7,665,000 | 6,577,000 | 5,961,000 | 5,145,000 | 5,176,000 | 5,551,000 | 6,155,000 | 5,058,000 | 5,358,000 | 5,121,000 | 4,447,000 | 4,447,000 | 4,771,000 | 4,279,000 | 4,230,000 | 3,724,000 | 3,276,000 | 3,002,000 | 2,623,000 | 2,973,000 | 2,406,000 | 2,590,000 | 2,451,000 | 2,230,000 | 1,894,000 | 2,216,000 | 1,926,000 | 1,196,000 |
| total costs and operating expenses | 81,100,000 | 74,615,000 | 67,658,000 | 61,423,000 | 60,031,000 | 46,391,000 | 34,851,000 | 34,295,000 | 35,756,000 | 35,923,000 | 33,436,000 | 33,509,000 | 32,182,000 | 31,020,000 | 30,357,000 | 31,682,000 | 31,949,000 | 27,570,000 | 21,692,000 | 19,882,000 | 19,453,000 | 19,223,000 | 23,657,000 | 23,973,000 | 22,249,000 | 20,150,000 | 17,787,000 | 15,314,000 | 14,212,000 | 13,795,000 | 13,203,000 | 15,719,000 | 18,777,000 | 16,147,000 | 12,983,000 | 9,715,000 | 11,548,000 | 10,967,000 | |||||||
| income from operations | -67,641,000 | -63,917,000 | -50,576,000 | -45,998,000 | -43,590,000 | -31,617,000 | -20,050,000 | -19,214,000 | -20,570,000 | -22,549,000 | -19,361,000 | -21,544,000 | -19,916,000 | -17,833,000 | -18,049,000 | -19,529,000 | -20,231,000 | -20,228,000 | -14,343,000 | -14,006,000 | -17,884,000 | -16,614,000 | -21,401,000 | -23,144,000 | -21,599,000 | -19,658,000 | -17,283,000 | -14,816,000 | -13,564,000 | -13,455,000 | -12,716,000 | -15,196,000 | -18,339,000 | -15,672,000 | -12,472,000 | -9,238,000 | -11,107,000 | -10,509,000 | -10,275,000 | -11,174,000 | -9,635,000 | -7,113,000 | -7,547,000 | -6,776,000 | -5,946,000 |
| yoy | 55.18% | 102.16% | 152.25% | 139.40% | 111.91% | 40.21% | 3.56% | -10.82% | 3.28% | 26.45% | 7.27% | 10.32% | -1.56% | -11.84% | 25.84% | 39.43% | 13.12% | 21.75% | -32.98% | -39.48% | -17.20% | -15.48% | 23.83% | 56.21% | 59.24% | 46.10% | 35.92% | -2.50% | -26.04% | -14.15% | 1.96% | 64.49% | 65.11% | 49.13% | 21.38% | -17.33% | 15.28% | 47.74% | 36.15% | 64.91% | 62.04% | ||||
| qoq | 5.83% | 26.38% | 9.95% | 5.52% | 37.87% | 57.69% | 4.35% | -6.59% | -8.78% | 16.47% | -10.13% | 8.17% | 11.68% | -1.20% | -7.58% | -3.47% | 0.01% | 41.03% | 2.41% | -21.68% | 7.64% | -22.37% | -7.53% | 7.15% | 9.87% | 13.74% | 16.65% | 9.23% | 0.81% | 5.81% | -16.32% | -17.14% | 17.02% | 25.66% | 35.01% | -16.83% | 5.69% | 2.28% | -8.05% | 15.97% | 35.46% | -5.75% | 11.38% | 13.96% | |
| operating margin % | -502.57% | -597.47% | -296.08% | -298.20% | -265.13% | -214.00% | -135.46% | -127.41% | -135.45% | -168.60% | -137.56% | -180.06% | -162.37% | -135.23% | -146.64% | -160.69% | -172.65% | -275.51% | -195.17% | -238.36% | -1139.83% | -636.80% | -948.63% | -2791.80% | -3322.92% | -3995.53% | -3429.17% | -2975.10% | -2093.21% | -3957.35% | -2611.09% | -2905.54% | -4186.99% | -3299.37% | -2294.54% | ||||||||||
| other income: | |||||||||||||||||||||||||||||||||||||||||||||
| interest income | 3,455,000 | 3,826,000 | 4,671,000 | 5,653,000 | 6,036,000 | 3,922,000 | 1,459,000 | 1,212,000 | 748,000 | 563,000 | 423,000 | 285,000 | 73,000 | 18,000 | 6,000 | 7,000 | 8,000 | 12,000 | 6,000 | 6,000 | 17,000 | 139,000 | 213,000 | 308,000 | 379,000 | 329,000 | 258,000 | 230,000 | 215,000 | 176,000 | 104,000 | 115,000 | 113,000 | 92,000 | 68,000 | 69,000 | 80,000 | 87,000 | 45,000 | 53,000 | 28,000 | 40,000 | 5,000 | 1,000 | |
| interest expense | -3,016,000 | -2,984,000 | -3,106,000 | -3,224,000 | -3,196,000 | -4,051,000 | -4,151,000 | -3,426,000 | -1,991,000 | -1,768,000 | -1,847,000 | -1,797,000 | -1,696,000 | -1,683,000 | -1,680,000 | -1,658,000 | -1,655,000 | -1,679,000 | -1,726,000 | -1,715,000 | -1,694,000 | -1,633,000 | -1,805,000 | -1,651,000 | -1,627,000 | -1,018,000 | -374,000 | -424,000 | -455,000 | -486,000 | -490,000 | -491,000 | -468,000 | -443,000 | -418,000 | -426,000 | -418,000 | -418,000 | -408,000 | -406,000 | -405,000 | -505,000 | -407,000 | -412,000 | -257,000 |
| change in fair value of derivative liabilities | -641,000 | -978,000 | 623,000 | 7,076,000 | -3,027,000 | -5,152,000 | -6,478,000 | 6,722,000 | |||||||||||||||||||||||||||||||||||||
| loss on extinguishment of debt | -27,950,000 | ||||||||||||||||||||||||||||||||||||||||||||
| gain on sale of property and equipment | 29,000 | ||||||||||||||||||||||||||||||||||||||||||||
| total other income | -173,000 | -136,000 | 2,188,000 | 9,505,000 | -187,000 | -33,231,000 | -9,170,000 | 18,698,000 | -112,000 | -7,769,000 | 3,819,000 | -2,644,000 | 1,150,000 | 5,291,000 | 14,199,000 | 22,186,000 | 11,750,000 | 23,349,000 | -71,269,000 | 2,062,000 | -18,684,000 | -4,898,000 | -4,616,000 | 4,366,000 | -2,854,000 | 2,534,000 | -116,000 | -194,000 | -240,000 | -310,000 | -386,000 | -371,000 | -355,000 | -351,000 | -350,000 | -358,000 | -338,000 | -331,000 | -362,000 | -350,000 | -374,000 | -465,000 | -407,000 | -518,000 | -446,000 |
| net income | -67,814,000 | -64,053,000 | -48,388,000 | -36,493,000 | -43,777,000 | -64,848,000 | -29,220,000 | -516,000 | -20,682,000 | -30,318,000 | -15,542,000 | -24,188,000 | -18,766,000 | -8,481,000 | -17,399,000 | -15,010,000 | -13,804,000 | -13,765,000 | -13,102,000 | -15,567,000 | -18,694,000 | -16,023,000 | -12,822,000 | -9,596,000 | -11,445,000 | -10,840,000 | -10,637,000 | -11,524,000 | -10,009,000 | ||||||||||||||||
| yoy | 54.91% | -1.23% | 65.60% | 6972.29% | 111.67% | 113.89% | 88.01% | -97.87% | 10.21% | 121.27% | 32.80% | -3.58% | -26.16% | -14.09% | 2.18% | 62.22% | 63.34% | 47.81% | 20.54% | -16.73% | 14.35% | ||||||||||||||||||||||||
| qoq | 5.87% | 32.37% | 32.60% | -16.64% | -32.49% | 121.93% | 5562.79% | -97.51% | -31.78% | 95.07% | -35.74% | 28.89% | 15.92% | 8.74% | 0.28% | 5.06% | -15.83% | -16.73% | 16.67% | 24.96% | 33.62% | -16.16% | 5.58% | 1.91% | -7.70% | 15.14% | |||||||||||||||||||
| net income margin % | -503.86% | -598.74% | -283.27% | -236.58% | -266.27% | -438.93% | -197.42% | -3.42% | -136.19% | -226.69% | -110.42% | -202.16% | -152.99% | 0% | 0% | 0% | -72.38% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -3452.18% | -3014.06% | -2130.25% | -4048.53% | -2690.35% | -2976.48% | -4268.04% | -3373.26% | -2366.81% | ||||||||||
| net income per share | -0.39 | -0.38 | -0.28 | -0.22 | -0.26 | -0.49 | -0.35 | -0.01 | -0.26 | -0.39 | -0.2 | -0.31 | -0.24 | -0.16 | -0.05 | 0.03 | -0.11 | 0.04 | -1.34 | -0.19 | -0.64 | -0.41 | -0.54 | -0.4 | -0.57 | -0.41 | -0.42 | -0.38 | -0.37 | -0.4 | -0.44 | -0.54 | -0.64 | -0.58 | -0.51 | -0.39 | -0.46 | -0.44 | -0.43 | -0.47 | -0.45 | -0.35 | 0.24 | -0.48 | -2.1 |
| weighted-average common shares outstanding, basic | 172,594,662 | 169,396,989 | 158,265,162 | 166,992,735 | 165,824,778 | 132,021,945 | 79,827,362 | 79,373,272 | 78,047,705 | 77,386,287 | 76,875,035 | 76,975,839 | 76,764,296 | 76,745,663 | 76,392,870 | 76,552,060 | 76,324,367 | 76,071,017 | 62,992,558 | 51,900,882 | 46,944,536 | 42,251,292 | |||||||||||||||||||||||
| weighted-average common shares outstanding, diluted | 172,594,662 | 169,396,989 | 158,265,162 | 166,992,735 | 165,824,778 | 132,021,945 | 85,596,594 | 85,142,504 | 78,047,705 | 77,386,287 | 82,644,267 | 76,975,839 | 82,533,528 | 82,514,895 | 82,162,102 | 85,446,886 | 82,093,599 | 87,245,706 | 68,761,790 | 51,900,882 | 52,713,768 | 44,174,369 | |||||||||||||||||||||||
| gains and losses on extinguishment of debt | 14,190,000 | ||||||||||||||||||||||||||||||||||||||||||||
| other income | -1,000 | 1,000 | -2,000 | 1,000 | 5,000 | -250 | -1,000 | 1,000 | 3,000 | 3,000 | -111,000 | -190,000 | |||||||||||||||||||||||||||||||||
| change in fair value of derivative liability | 1,131,000 | -6,563,000 | 5,243,000 | -1,133,000 | 2,773,000 | 6,958,000 | 15,872,000 | 23,837,000 | 13,396,000 | 25,016,000 | -69,549,000 | 3,771,000 | -17,007,000 | -3,404,000 | -3,024,000 | 5,717,000 | -1,606,000 | 3,223,000 | |||||||||||||||||||||||||||
| net (loss) per share, diluted | -0.183 | -0.31 | |||||||||||||||||||||||||||||||||||||||||||
| net income attributable to common stockholders | -12,542,000 | 3,121,000 | -10,637,000 | -11,524,000 | -10,009,000 | -7,578,000 | -7,954,000 | -7,294,000 | -6,397,000 | ||||||||||||||||||||||||||||||||||||
| net income and comprehensive income | -675,750 | 2,657,000 | |||||||||||||||||||||||||||||||||||||||||||
| net income and comprehensive loss | -85,612,000 | -11,944,000 | -36,568,000 | -21,512,000 | -26,017,000 | -18,778,000 | -24,453,000 | -17,124,000 | -7,578,000 | -7,954,000 | -7,294,000 | -6,392,000 | |||||||||||||||||||||||||||||||||
| weighted-average common shares outstanding, basic and diluted | 60,752,225 | 57,368,292 | 45,273,231 | 42,910,084 | 38,115,142 | 39,017,922 | 37,524,512 | 34,792,848 | 28,818 | 29,087,654 | 29,026,259 | 27,643,746 | 24,816 | 24,853,880 | 24,770,059 | 24,751,682 | 23,244,162 | 24,713,597 | 22,167,274 | 21,362,731 | 10,652,865 | 15,165,612 | 3,044,605 | ||||||||||||||||||||||
| comprehensive loss: | |||||||||||||||||||||||||||||||||||||||||||||
| other comprehensive loss: | |||||||||||||||||||||||||||||||||||||||||||||
| unrealized gain on marketable securities | 1.25 | 9 | 18.25 | -5 | 10 | ||||||||||||||||||||||||||||||||||||||||
| total other comprehensive income | 1.25 | 9 | 18.25 | -5 | 10 | 68 | |||||||||||||||||||||||||||||||||||||||
| total comprehensive loss | -17,399 | -15,010 | -13,804 | -13,765 | -12,569.75 | -15,567 | -18,685 | -16,027 | -7,952 | -9,601 | -11,435 | -10,772 | -10,689 | -11,532 | -10,017 | ||||||||||||||||||||||||||||||
| unrealized loss on marketable securities | -52 | -8 | -8 | ||||||||||||||||||||||||||||||||||||||||||
| total other comprehensive loss | -52 | -8 | -8 | ||||||||||||||||||||||||||||||||||||||||||
| other comprehensive income: | |||||||||||||||||||||||||||||||||||||||||||||
| total revenue: | 344,000 | 477,000 | 441,000 | 328,500 | 429,000 | 459,000 | 426,000 | ||||||||||||||||||||||||||||||||||||||
| unrealized gains on marketable securities | 68 | ||||||||||||||||||||||||||||||||||||||||||||
| operating expenses: | |||||||||||||||||||||||||||||||||||||||||||||
| total operating expenses | 10,711,000 | 11,603,000 | 10,094,000 | 7,539,000 | 8,052,000 | 6,919,000 | 6,043,000 | ||||||||||||||||||||||||||||||||||||||
| accretion of redeemable convertible preferred stock to redemption value | -5,000 | ||||||||||||||||||||||||||||||||||||||||||||
| revenue | 66,750 | 143,000 | 97,000 | ||||||||||||||||||||||||||||||||||||||||||
| cost of revenue | 15,250 | 32,000 | 20,000 | ||||||||||||||||||||||||||||||||||||||||||
| gross profit | |||||||||||||||||||||||||||||||||||||||||||||
| yoy | |||||||||||||||||||||||||||||||||||||||||||||
| qoq | |||||||||||||||||||||||||||||||||||||||||||||
| gross margin % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
We provide you with 20 years income statements for Ocular Therapeutix stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Ocular Therapeutix stock. Explore the full financial landscape of Ocular Therapeutix stock with our expertly curated income statements.
The information provided in this report about Ocular Therapeutix stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.